The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spatial interactions between immune cells as a predictor of pCR to neoadjuvant chemotherapy (NACT) and nivolumab for ER+/HER2- breast cancer (BC): Analysis of the phase II GIADA trial.
 
Valentina Guarneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD; Novartis; Olema Oncology; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Abbvie; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini Steamline; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead/Forty Seven; Menarini Group; Roche
 
Gaia Griguolo
Consulting or Advisory Role - Gilead Sciences; Menarini; Seagen
Speakers' Bureau - Lilly; MSD
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Anna Tosi
No Relationships to Disclose
 
Filippo Giovanardi
No Relationships to Disclose
 
Antonino Musolino
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai Europe; Lilly; Novartis
Research Funding - Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Simon Spazzapan
Honoraria - AstraZeneka/MSD; Daiichi-Sanckyo; Gentili; Novartis; Seagen
Consulting or Advisory Role - AstraZeneka/Daiichi-Sanckyo; MSD/AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo Italia; Novartis; Pfizer Italia; Roche
 
Grazia Vernaci
Honoraria - AstraZeneca; Daiichi Sankyo; Novartis
 
Tommaso Giarratano
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Lilly; Novartis
 
Stefania Lando
No Relationships to Disclose
 
Gian Luca De Salvo
No Relationships to Disclose
 
Antonio Rosato
No Relationships to Disclose
 
Angelo Dei Tos
No Relationships to Disclose
 
Maria Vittoria Dieci
Honoraria - AstraZeneca; daiichi-sankyo; Lilly; Menarini Group
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - reveal genomics - listed as co-inventor in patent applications for HER2DX
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Roche